Skip to main content

Remote Job Finders (RJF)

After COVID, biomanufacturing tackles preparedness and commercialization challenges

Manufacturers are redesigning their processes to balance both better future emergency vaccine mobilization and the more demanding work of maintaining flexible, commercially viable manufacturing networks.

Nektar prevails in legal battle with Lilly over broken rezpeg partnership

Nektar Therapeutics has been awarded $90 million in damages after a jury sided with the biotech, which had accused Big Pharma Eli Lilly of “botching” an analysis of their formerly partnered autoimmune drug.
Scroll to top